Open replacement of heart valves (all valves)

The report presents a summary of reimbursement situation for open replacement of heart valves (aortic, mitral, tricuspid and pulmonary).

Report includes information about two types of prosthetic heart valves:

• biological valves
• mechanical prosthetic valves

Open replacement of heart valves will be analyzed in conjunction with open coronary artery bypass grafting (CABG).

The following indications will be considered:

• Aortic stenosis
• Mitral insufficiency
• Tricuspid insufficiency
• Pulmonary valve insufficiency

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

• Brief overview of reimbursement system for medical devices
• Procedure coding for technology
• Diagnosis coding
• Payment mechanism for technology
• Reimbursement tariffs for technology
• Restrictions in indications or scenarios for use of technology
• Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

• Austria
• Belgium
• Denmark
• England (UK)
• France
• Germany
• Italy
• Netherlands
• Norway
• Sweden
• Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for heart valves (for open or thoracoscopic placement, not percutaneous)

• Abbott Vascular (Trifecta, SJM Regent, Epic™ Mitral)
• CryoLife Life Technologies, Inc. (On-X)
• Edwards Lifesciences (INSPIRIS RESILIA, EDWARDS INTUITY Elite, Carpentier-Edwards PERIMOUNT  Magna-Ease)
• Labcor (Dokimos Plus)
• Lepu Medical (GK-3)
• LivaNova (Perceval, Crown PRT, Solo Smart, Mitroflow with PRT, Bicarbon Aortic Family, Carbomedic Aortic family)
• Medtronic (Avalus Bioprosthesis, Hancock II, Hancock II Ultra, Mosaic, Mosaic Ultra, Freestyle, Open Pivot)
• TTK Healthcare (Chitra)